UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported):

~~January~~February 292, 2026

CommissionFile Number	Exact Name of Registrant as Specified in its Charter,Principal Office Address and Telephone Number	State or Other Jurisdiction of Incorporation	I.R.S. EmployerIdentification No.
001-38646	Dow Inc.	Delaware	30-1128146
	2211 H.H. Dow Way, Midland, MI 48674
	(989) 636-1000
001-03433	The Dow Chemical Company	Delaware	38-1285128
	2211 H.H. Dow Way, Midland, MI 48674
	(989) 636-1000

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Registrant			Title of each class			Trading Symbol(s)			Name of each exchange on which registered
Dow Inc.			Common Stock, par value $0.01 per share			DOW			New York Stock Exchange

Securities registered pursuant to Section 12(b) of the Act:


Registrant	Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Dow Inc.	Common Stock, par value $0.01 per share	DOW	New York Stock Exchange
The Dow Chemical Company	0.500% Notes due March 15, 2027	DOW/27	New York Stock Exchange
The Dow Chemical Company	1.125% Notes due March 15, 2032	DOW/32	New York Stock Exchange
The Dow Chemical Company	1.875% Notes due March 15, 2040	DOW/40	New York Stock Exchange
The Dow Chemical Company	4.625% Notes due October 1, 2044	DOW/44	New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Dow Inc. Emerging ~~growth~~Growth ~~company ¨~~Company ☐ The Dow Chemical Company Emerging Growth Company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

~~Section~~Dow 2Inc. -☐ ~~Financial~~The ~~Information~~Dow Chemical Company ☐

~~Item~~Section ~~2.02~~8 ~~Results~~- ofOther ~~Operations and Financial Condition.~~Events

OnItem ~~January 29, 2026, Dow Inc~~8.01 ~~issued~~Other ~~a press release, attached as Exhibit 99~~Events.~~1 and incorporated herein by reference, announcing results for the fourth quarter of 2025.~~

The ~~information~~document ~~contained~~listed inbelow ~~this~~(the ~~report,~~"Document") ~~including~~is ~~Exhibit~~required ~~99.1 attached~~to ~~hereto,~~be isfiled ~~being~~as ~~furnished~~an ~~and~~exhibit ~~shall~~to ~~not~~the beDow ~~deemed~~Inc. ~~"filed"~~and ~~for~~The ~~purposes~~Dow ofChemical ~~Section~~Company 18Annual ofReport on Form 10-K (the ~~Securities~~"10‑K") ~~Exchange~~for ~~Act~~the ofyear ~~1934~~ended December 31, as2025. ~~amended,~~For oradministrative ~~otherwise~~convenience ~~subject~~and to avoid further increasing the ~~liabilities~~size of ~~Section 18.~~the ~~Furthermore~~10-K, ~~the~~Dow ~~information~~Inc. ~~contained~~and inThe ~~this~~Dow ~~report~~Chemical ~~shall~~Company ~~not~~are befiling ~~deemed~~the toDocument beas ~~incorporated~~an byexhibit ~~reference~~to ~~into~~this ~~any~~optional ~~registration~~Current ~~statement~~Report oron ~~other~~Form ~~document~~8-K ~~filed~~and ~~pursuant~~will toincorporate the ~~Securities~~Document ~~Act~~into ofthe ~~1933,~~10‑K asby ~~amended~~reference hereto.

Section 9 - Financial Statements and Exhibits

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits. The ~~exhibit~~exhibits listed on the Exhibit Index isare incorporated herein by reference.

Exhibit No.			Exhibit Description
99.1			Press release issued by Dow Inc. on January 29, 2026, announcing results for the fourth quarter of 2025.
4.5			Description of Securities registered under Section 12 of the Securities Exchange Act of 1934.
104			Cover Page Interactive Data File. The cover page interactive data file does not appear in the Interactive Data File because its XBRL tags are embedded with the Inline XBRL document.

Signature

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

DOW INC.

~~Date:~~THE ~~January 29,~~DOW ~~2026~~CHEMICAL COMPANY

~~/s/~~Date: ~~ANDREA~~February 2, ~~L. DOMINOWSKI Andrea L. DominowskiController and Vice Presidentof Controllers~~2026


/s/ ANDREA L. DOMINOWSKI
Andrea L. Dominowski Controller and Vice President of Controllers (Authorized Signatory and Principal Accounting Officer)

Filing Compare · DOW INC.